Catalyst Wire Dossier Catalyst Wire Dossier

Aimmune Therapeutics Peanut Oral Immunotherapy

peanut oral immunotherapy · Aimmune Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aimmune Therapeutics Peanut Oral Immunotherapy, covering 2023-03-02 to 2023-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Peanut Oral Immunotherapy Study of Early Intervention for Desensitization [Phase 3]

See pricing